Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

No carcinogenicity studies are available for PERKALINK 900. However, the substance did not show mutagenic effects in in vivo genotoxicity tests and there is no indication for preneoplastic lesions in repeated dose toxicity studies with up to subchronic exposure. Thus, a carcinogenic potential of PERKALINK 900 can be considered as unlikely.

Key value for chemical safety assessment

Justification for classification or non-classification

Additional information

No carcinogenicity studies are available for PERKALINK 900. However, the substance did not show mutagenic effects in in vivo genotoxicity tests and there is no indication for preneoplastic lesions in repeated dose toxicity studies with up to subchronic exposure. Thus, a carcinogenic potential of PERKALINK 900 can be considered as unlikely.